Replimune (REPL) Debt to Equity (2023 - 2025)
Replimune's (REPL) quarterly Debt to Equity came in at $0.23 in Q4 2025, up 137.43% year-on-year from $0.1 in Q4 2024, and up 26.2% quarter-over-quarter from $0.18 in Q3 2025.
Replimune (REPL) Debt to Equity (2023 - 2025) Analysis & Trends
Replimune has disclosed Debt to Equity across 3 years of filings, most recently posting $0.23 for Q4 2025.
- Debt to Equity for Q4 2025 came in at $0.23, up 137.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.23 (up 137.43% YoY), and the FY2025 annual result was $0.11, down 6.79% from the prior year.
- Debt to Equity came in at $0.23 for Q4 2025 at Replimune, up from $0.18 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.23 in Q4 2025 to a low of $0.05 in Q1 2023.
- The 3-year median for Debt to Equity is $0.12 (2024), against an average of $0.13.
- Peak annual rise in Debt to Equity reached 137.43% in 2025, while the deepest fall reached 6.79% in 2025.
- Replimune's Debt to Equity stood at $0.05 in 2023, then jumped by 84.68% to $0.1 in 2024, then soared by 137.43% to $0.23 in 2025.
- The last three Debt to Equity figures came in at $0.23 (Q4 2025), $0.18 (Q3 2025), and $0.14 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | 0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.23 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.10 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.11 |
| Mar 31, 2024 | 0.12 |
| Mar 31, 2023 | 0.05 |